


The BIOINVISIBLE™ solution
The human body is well served by efficient defence mechanisms, which pose several biochemical challenges in the design of blood-contacting devices such as stents and vascular grafts, as well as non-vascular implants.
Currently, medical device complications result in implant failure rates of up to 30%, leaving many patients requiring additional medical intervention and surgery causing significant discomfort, morbidity or even death.
BIOINVISIBLE™ is the solution to reducing this failure rate.
TekCyte has a novel and simple process for applying a well-characterised biocompatible polymer, hyperbranched polyglycerol (HPG) onto implantable materials, rendering them ‘invisible’ to the body’s normal defences.